GRACE THERAPEUTICS
Grace Therapeutics is a pharmaceutical company with a focus on rare and orphan diseases. Grace's strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique evidence-based and outcomes-driven value proposition . ITs pipeline consists of three distinct assets all in late stage clinical development for the treatment of Postherpetic Neuralgia, Subarachnoid Hemorrhage, and Ataxia Telangiectasia. We intend to pursue multiple commercialization options for these products including their proprietary platform technologies for maximum value creation.
GRACE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Founded:
2014-01-01
Address:
East Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.gtrx.com
Total Employee:
1+
Status:
Active
Contact:
+1 646 809 - 6839
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Amazon Virginia Region Pound Sterling Hornetsecurity
Similar Organizations
4P Therapeutics
4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics.
Apex Scientific
Apex Scientific is a specialized company that focuses on chromatography, sample preparation, liquid handling, and all related areas.
Auxeris Therapeutics
Auxeris Therapeutics is a biopharmaceutical company focused on the treatment of bone diseases.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Constant Therapeutics
Constant Therapeutics is a biopharmaceutical company that develops drugs and therapies, with clinical trials for a range of diseases.
Episurf Medical
Episurf is a medical company that focuses on helping people with painful joint injuries have a more active, healthier life.
GSL Solutions
GSL Solutions is a medical technology company that develops devices for storing and tracking controlled substances.
Halo Health Systems
Halo Health Systems is a healthcare company that focuses on patient-centric trials to lower patient and location burden.
LTS - Lohmann Therapy Systems
Lohmann Therapy Systems is a pharmaceuticals company that provides LTS transdermal drug delivery system information.
MedGrocer
MedGrocer is a pharmaceutical company that delivers prescription and OTC medicines.
Metris Therapeutics
Metris Therapeutics is a pharmaceutical company that focuses on developing treatments for gynecological conditions.
NextPhase Therapeutics
NextPhase Therapeutics is a drug discovery firm that offers novel biological topical treatment for autoimmune diseases.
Othera Pharmaceuticals
Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Surgicure Technologies
Surgicure is a start-up company that is dedicated to building effective medical instruments to prevent unnecessary harm.
Tibotec
Tibotec is a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV .
Zander Therapeutics Inc
Zander Therapeutics Inc is a veterinary biotechnology firm that focuses on developing veterinary treatments for cancer disorders.
Current Employees Featured
Founder
Official Site Inspections
http://www.gtrx.com
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Grace Therapeutics"
GTRx - Genome-to-Treatment - RCIGM
Request Access to Genome-To-Treatment (GTRx™) is a first step in ending the therapeutic odyssey for rare genetic conditions. GTRx is a virtual, automated system for frontline clinicians in intensive care settings that provides …See details»
Study Supports Potential of Genome-to-Treatment …
Jul 26, 2022 “GTRx is intended to provide immediate guidance to frontline neonatologists and intensivists to select optimal therapies for critically ill infants and children in intensive care units as time is of the essence,” said Stephen …See details»
Automated Genome-to-Treatment System Could Help Manage …
Jul 26, 2022 “We developed GTRx to both increase the number of children who receive optimal, immediate treatment and to facilitate broader use of rapid whole genome sequencing by …See details»
Clinical Decision Support Tool Provides Effective Precision …
Jul 28, 2022 The tool, known as Genome-to-Treatment (GTRx), is a virtual disease management system that integrates whole genome sequencing to provide diagnostics and guidance for 500 …See details»
Study supports potential of genome-to-treatme | EurekAlert!
Jul 26, 2022 Study supports potential of genome-to-treatment (GTRx™) to guide physicians in the management of 500 treatable genetic diseases GTRx, a clinical decision support tool, can …See details»
Grace Therapeutics - Crunchbase Company Profile & Funding
Organization. Grace Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Phone …See details»
An automated 13.5 hour system for scalable diagnosis and acute
Jul 26, 2022 The 421 (75%) diseases and 1527 (15%) effective interventions retained are integrated with 13 genetic disease information resources and appended to diagnostic reports ( …See details»
Study supports potential of genome-to-treatment to guide …
Jul 26, 2022 Rady Children's Institute for Genomic Medicine (RCIGM) today announced the publication of a study in Nature Communications describing and examining the performance of …See details»
An automated 13.5 hour system for scalable diagnosis and acute ...
Jul 26, 2022 Finally, the 13.5-h system featured a virtual clinical decision support system, Gene-to-Treatment (GTRx SM, https://gtrx.radygenomiclab.com) to decrease variability or delayed …See details»
Rady Children's Team Presents Genomic Medicine Management
Oct 20, 2021 NEW YORK – A Rady Children's Institute for Genomic Medicine-led team has developed an automated management guidance system for pediatric patients with rare genetic …See details»
Researchers propose a solution to delayed molecular diagnosis …
Jul 28, 2022 Rady Children’s Institute for Genomic Medicine (RCIGM®) recently announced the publication in Nature Communications of research that describes and examines the efficiency …See details»
BeginNGS Publications | RCIGM
The 421 (75%) diseases and 1527 (15%) effective interventions retained are integrated with 13 genetic disease information resources and appended to diagnostic reports …See details»
eP286: Genome-to-treatment: A system to guide ... - Genetics in …
Many rare genetic diseases have effective treatments. Without immediate implementation many progress rapidly to severe morbidity or mortality. Front-line physicians frequently lack …See details»
eP286: Genome-to-treatment: A system to guide the acute …
Mar 1, 2022 GTRx has the potential to facilitate broad implementation of optimal acute management for children with rapidly progressive genetic diseases by front-line ICU …See details»
Study supports potential of genome-to-treatment to guide …
Another important partner in the development of GTRx, Illumina, contributed genome sequencing library preparation, sequencing, analysis, and data integration technologies that enabled the …See details»
RadysGenomic
A virtual, automated system for acute management guidance for seriously ill newborns, infants and children with newly diagnosed genetic diseases.See details»
An automated 13.5 hour system for scalable diagnosis and acute ...
Jul 26, 2022 The 421 (75%) diseases and 1527 (15%) effective interventions retained are integrated with 13 genetic disease information resources and appended to diagnostic reports ( …See details»
Flowchart of the development of Genome-To-Treatment (GTRx), a …
Download scientific diagram | Flowchart of the development of Genome-To-Treatment (GTRx), a virtual system for acute management guidance for rare genetic diseases Phase 1 - …See details»
Dispatches from Biotech beginning BeginNGS: Rapid newborn …
Each GTRx intervention prescribed and outcome assessed informs the retention of that gene-disorder dyad in rWGS-based NBS. 3 DISCUSSION BeginNGS was informed by a decade of …See details»
Goldman Sachs Small Cp Val Insghts R GTTRX - Morningstar
Sep 30, 2024 Goldman Sachs Sm Cp Val Insghts Fd earns an Above Average Process Pillar rating. The most substantial contributor to the rating is the fund's excellent long-term risk …See details»